natgillin/translations-raw huggingface dataset:
Cyclocaps Beclometason Beclometasone Dipropionate 100µg Units 
Cyclocaps Beclometason Beklometazon dipropionat 100 µg jedinice
Beclometasone Dipropionate 100µg Inhalation, Formoterol Fumarate 6µg Inhalation 
Beklometazon dipropionat 100 µg inhalat, formoterol fumarat 6 µg inhalat
Fluticasone Propionate 500µg, Salmeterol Xinafoate 72,5µg 
Flutikazon propionat 500 µg, salmeterol ksinafoat 72,5 µg
Budesonide 200µg 
Budezonid 200 µg
Cyclocaps Beclometason Beclometasone Dipropionate 200µg Units 
Cyclocaps Beclometason Beklometazon dipropionat 200 µg jedinice
Budesonide, Micronised 0.2mg Actuation 
Budezonid, mikronizirani 0,2 mg po aktuaciji
Fluticasone Propionate 125µg Inhalation 
Flutikazon propionat 125 µg inhalat
Budesonide 160µg Inhalation, Formoterol Fumarate Dihydrate 4.5µg Inhalation 
Budezonid 160 µg inhalat, formoterol fumarat dihidrat 4,5 µg inhalat
Budesonide 0.5mg Ampoule 
Budezonid 0,5 mg ampula
Belgium Pari Pharma Gmbh 
Njemačka Pari Pharma Gmbh
Budesonide 320µg, Formoterol Fumarate Dihydrate 9µg 
Budezonid 320 µg, formoterol fumarat dihidrat 9 µg
Budesonide 160µg, Formoterol Fumarate Dihydrate 4.5µg 
Budezonid 160 µg, formoterol fumarat dihidrat 4,5 µg
Glaxosmithkline Export Ltd 
Glaxosmithkline Export
Budesonide 800µg Units 
Cyclocaps Budesonid Budezonid 800 µg jedinice
Beclometasone Dipropionate 100g/5ml 
Beklometazon dipropionat 100 g/5 ml
Fluticasone Propionate 250µg Inhalation 
Flutikazon propionat 250 µg inhalat
Budesonide 1,0 Mg 
Pulmicort Budesonide Budezonid 1,0 Mg
Fluticasone Propionate 250mcg/Dose Inhalation Powder 
Flutikazon propionat doza od 250 mcg Prašak inhalata
Budesonide 320µg Inhalation, Formoterol Fumarate Dihydrate 9µg Inhalation 
Budezonid 320 µg inhalat, formoterol fumarat dihidrat 9 µg inhalat
Beclometasone Dipropionate 100µg Actuation, Formoterol Fumarate Dihydrate 6µg Dose 
Beklometazon dipropionat 100 µg po aktuaciji, formoterol fumarat dihidrat doza od 6 µg
Formoterol Fumarate Dihydrate 6µg Dose, Beclometasone Dipropionate Anhydrous 100µg Dose 
Formoterol fumarat dihidrat doza od 6 µg, beklometazon dipropionat bezvodni doza od 100 µg
Fluticasone Propionate 50µg Inhalation 
Flutikazon propionat 50 µg inhalat
Fluticasone Propionate 125µg Dose Aerosol 
Flutikazon propionat doza od 125 µg Aerosol
Budesonide 200µg Spray 
Budezonid 200 µg sprej
Glaxosmithkline S.A. 
Španjolska Glaxosmithkline S.A.
Budesonide 0.2mg Dose 
Budezonid doza od 0,2 mg
Budesonide 400µg Inhalation 
Budezonid 200 µg inhalacija
Budesonide 100µg Units 
Cyclocaps Budesonid Budezonid 100 µg jedinice
Budesonide 320µg Dose, Formoterol Fumarate Dihydrate Ph.Eur. 
Budezonid doza od 320 µg, formoterol fumarat dihidrat Ph.Eur. doza od 9 µg
Salmeterol 25µg/Dose; Fluticasone Propionate 125µg/Dose 
Salmaterol doza od 25 µg; flutikazon propionat doza od 125 µg
Beclometasone Dipropionate 0.2mg Dose 
Beklometazon dipropionat doza od 0,2 mg
Beclometasone Dipropionate 100µg Actuation, Formoterol Fumarate Dihydrate 6µg Actuation 
Beklometazon dipropionat 100 µg po aktuaciji, formoterol fumarat dihidrat 6µg po aktuaciji
Fluticasone Propionate 250µg Dose Aerosol 
Flutikazon propionat doza od 250 µg Aerosol
Budesonide, Micronised 400µg Dose Inhalation Powder 
Budezonid, mikronizirani, doza od 400 µg
Fluticasone Propionate 250 Mcg Dose, Salmeterol Xinafoate 50 Mcg Dose 
Flutikazon propionat doza od 250 Mcg, salmeterol ksinafoat doza od 50 Mcg
Beclometasone Dipropionate 0.2mg/18.7g 
Beklometazon dipropionat 0,2 mg/18,7 g
Fluticasone Propionate 250mcg/Dose Pressurised Inhalation, 
Flutikazon propionat doza od 250 mcg Stlačeni inhalat, suspenzija
Beclometasone Dipropionate 0.1mg/18.7g 
Beklometazon dipropionat 0,1 mg/18,7 g
Fluticasone Propionate 100 Mcg Dose, Salmeterol Xinafoate 50 Mcg Dose 
Flutikazon propionat doza od 100 Mcg, salmeterol ksinafoat doza od 50 Mcg
Fluticasone Propionate 500 Mcg Dose, Salmeterol Xinafoate 50 Mcg Dose 
Flutikazon propionat doza od 500 Mcg, salmeterol ksinafoat doza od 50 Mcg
Fluticasone Propionate 250µg 
Flutikazon propionat 250 µg sprej
Glaxosmithkline Gmbh & Co. Kg Viani Forte 
Njemačka Glaxosmithkline Gmbh & Co.
Fluticasone Propionate 125µg Dose Pressurised Inhalation 
Flutikazon propionat doza od 125 µg Stlačeni inhalat
Samtoral Diskus Standard Fluticasone Propionate 250µg Dose, Salmeterol 50µg Dose 
Flutikazon propionat doza od 250 µg, salmeterol 50 µg
Salmeterol Xinafoate 50µg Dose, Fluticasone Propionate 250µg Dose 
Salmeterol ksinafoat doza od 50 µg, flutikazon propionat doza od 250 µg
Beclometasone Dipropionate 0.05mg/18.7 G 
Beklometazon dipropionat 0,05 mg/18,7 G
Budesonide 0,5 Mg 
Pulmicort Budesonide Budezonid 0,5 Mg
Fluticasone Propionate 125µg Dose Pressurised Inhalation, 
Flutikazon propionat doza od 125 µg Stlačeni inhalat, suspenzija
Formoterol Fumarate Dihydrate 6µg Actuation, Beclometasone Dipropionate Anhydrous 100µg Actuation 
Formoterol fumarat dihidrat doza od 6 µg po aktuaciji, beklometazon dipropionat bezvodni 100 µg po aktuaciji
Fluticasonpropionat „allen“ Fluticasone Propionate 250µg Dose Inhalation Powder 
Kg Flixotide Forte Diskus Flutikazon propionat doza od 500 µg Prašak inhalata
Fluticasone Propionate 250µg Inhalation, Salmeterol Xinafoate 25µg Inhalation 
Flutikazon propionat 250 µg inhalat, salmeterol ksinafoat 25 µg inhalat
Salmeterol Xinafoate 50µg Dose, Fluticasone 250µg Dose 
Salmeterol ksinafoat doza od 50 µg, flutikazon doza od 250 µg
Belgium Elpen Pharmaceutical Co. Inc. 
Rumunjska Elpen Pharmaceutical Co.
Fluticasone Propionate 250µg Dose Pressurised Inhalation 
Flutikazon propionat doza od 250 µg Stlačeni inhalat
Salmeterol Xinafoate 50µg Dose, Fluticasone Propionate 500µg Dose 
Salmeterol ksinafoat doza od 50 µg, flutikazon propionat doza od 500 µg
Fluticasone Propionate 500µg Dose Inhalation Powder, Pre-Dispensed 
Flutikazon propionat doza od 500 µg Prašak inhalata, dozirani
Fluticasone Propionate 250µg Dose Inhalation Powder, Pre-Dispensed 
Flutikazon propionat doza od 250 µg Prašak inhalata, dozirani
Salmeterol 50µg Dose, Fluticasone Propionate 500µg Dose 
Salmaterol doza od 50 µg, flutikazon propionat doza od 500 µg
Budesonide 160µg Dose, Formoterol Fumarate Dihydrate Ph.Eur. 
Budezonid doza od 160 µg, formoterol fumarat dihidrat Ph.Eur. doza od 4,5 µg
Heumann Pharma Gmbh & Co. Generica Kg 
Njemačka Heumann Pharma Gmbh & Co.
Salmeterol Xinafoate 50µg Dose, Fluticasone 500µg Dose 
Salmeterol ksinafoat doza od 50 µg, flutikazon doza od 500 µg
Fluticasone Propionate 500µg Inhalation 
Flutikazon propionat 500 µg inhalat
Fluticasone Propionate 250µg Dose Pressurised Inhalation, 
Flutikazon propionat doza od 250 µg Stlačeni inhalat, suspenzija
Fluticasone Propionate 500µg Inhalation, Salmeterol 50µg Inhalation 
Atmadisc Forte Diskus Flutikazon propionat 500 µg inhalat, salmeterol 50 µg inhalat
Below is a list of examples of these types of medicines: 
U nastavku se nalazi popis primjera ovih vrsta lijekova:
Important things to be aware of: 
Važne stvari kojih morate biti svjesni:
This may take 5-10 minutes. 
5-10 minuta.
• Take the dose once a day by placing the tablets under the tongue. 
• Uzmite dozu jednom dnevno stavljanjem tableta pod jezik.
Suboxone with food, drink and alcohol 
Suboxone s hranom, pićem i alkoholom
You may be unable to think clearly, and may breathe much slower than is normal for you. 
Možda nećete moći jasno razmišljati, ili ćete disati puno sporije nego što je uobičajeno.
1 - Do not push the tablet through the foil. 
1 - Ne gurajte tabletu kroz foliju.
Date of latest renewal: 26 September 2011 
Datum posljednje obnove: 26. rujna 2011.
• recently suffered a head injury or brain disease 
• ako ste nedavno zadobili ozljedu glave ili imali bolest mozga
United Kingdom. 
Velika Britanija.
These may be signs of a life-threatening allergic reaction. 
Ovo mogu biti znakovi životno ugrožavajuće alergijske reakcije.
Use in adolescents (Age 15-<18) 
Primjena u adolescenata (dob od 15 do <18)
Acute alcoholism or delirium tremens. 
Akutni alkoholizam ili delirium tremens
PK Parameter 
PK parametar
What Suboxone is and what it is used for 
Što je Suboxone i za što se koristi
Due to the lack of data in adolescents (age 15-<18), patients in this age group should be more closely monitored during treatment. 
S obzirom na nedostatak podataka u adolescenata (u dobi od 15 do <18), bolesnici ove dobne skupine moraju se pažljivije pratiti tijekom liječenja.
Therefore, dosages must be limited and this combination must be avoided in cases where there is a risk of misuse. 
Zbog toga doze moraju biti ograničene i ta se kombinacija lijekova mora izbjegavati u slučajevima u kojima postoji rizik od zlouporabe.
• some medicines may decrease the effect of Suboxone. 
• neki lijekovi mogu smanjiti učinke lijeka Suboxone.
In some patients, after a satisfactory stabilisation has been achieved, the frequency of dosing may be decreased to 3 times a week (for example on Monday, Wednesday and Friday). 
U nekih bolesnika učestalost primjene, nakon što je postignuta zadovoljavajuća stabilizacija, može se smanjiti na 3 puta tjedno (na primjer, ponedjeljkom, srijedom i petkom).
Regular blood tests may be conducted by your doctor to monitor the condition of your liver. 
Vaš liječnik može provoditi redovite krvne pretrage kako bi nadzirao stanje Vaše jetre.
• Additional monitoring 
• Dodatno praćenje
You may be more closely monitored by your doctor if you are below the age of 18 or over the age of 65. 
Vaš liječnik će Vas pomnije pratiti ako imate manje od 18 ili više od 65 godina.
Email: PatientSafetyRoW@indivior.com 
E-mail PatientSafetyRoW@indivior.com
Suboxone is used in adults and adolescents over 15 years of age, who are also receiving medical, social and psychological support. 
Suboxone se koristi u odraslih osoba i adolescenata starijih od 15 godina, koji također primaju medicinsku, socijalnu i psihološku pomoć.
The patient should be transferred to an environment within which full resuscitation facilities are available. 
Bolesnika treba premjestiti na odjel gdje postoji kompletna oprema za oživljavanje.
2 - Remove just one section from the blister pack, tearing it along the perforated line. 
2 - Odvojite samo jedan odjeljak od blistera, kidajući ga uzduž perforirane linije.
Content of the pack and other Information 
Sadržaj pakiranja i druge informacije
No synergistic enhancement of toxicity has been observed. 
Nije primjećeno sinergističko pojačanje toksičnosti.
• any liver disease such as hepatitis 
• bilo koju bolest jetre poput hepatitisa
This may happen more often in the first few weeks of treatment when your dose is being changed, but can also happen if you drink alcohol or take other sedative medicines when you take Suboxone. 
Do ovog može doći češće u prvih nekoliko tjedana liječenja kada Vam se mijenja doza, no također se može pojaviti ako uz Suboxone konzumirate alkohol ili uzimate druge sedative.
• Do not chew or swallow the tablets, as the medicine will not work and you may get withdrawal symptoms. 
• Nemojte žvakati ili gutati tablete, jer lijek neće djelovati i možete imati simptome ustezanja.
If you have the impression that the effect of Suboxone is too strong or too weak, talk to your doctor or pharmacist. 
Ako imate dojam da je učinak lijeka Suboxone prejak ili preslab, razgovarajte sa svojim liječnikom ili ljekarnikom.
When a hepatic event is suspected, further biological and etiological evaluation is required. 
Kad se sumnja na jetreni događaj, potrebna su daljnja biološka i etiološka ispitivanja.
The frequency of possible side effects listed below is defined using the following convention: Very common (1/10), Common (1/100 to <1/10), Uncommon (1/1,000 to <1/100), Not known (cannot be estimated from available data). 
Učestalost mogućih nuspojava navedenih u nastavku definirana je na sljedeći način: vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1000 i <1/100), nepoznato (ne može se procijeniti iz dostupnih podataka).
Suboxone can also cause withdrawal symptoms if you stop taking it abruptly. 
Suboxone može također uzrokovati simptome ustezanja ako ga naglo prestanete uzimati.
• alcoholic drinks or medicines containing alcohol, as alcohol increases the sedative effect of buprenorphine (see section 4.7). 
• alkoholnim pićima ili lijekovima koji sadrže alkohol, jer alkohol pojačava sedativni učinak buprenorfina (vidjeti dio 4.7).
• asthma or other breathing problems 
• astmu ili bilo koji drugi problem s disanjem
Suboxone should not be taken together with: 
Suboxone ne bi trebalo uzimati zajedno s:
Some medicines may increase the side effects of Suboxone and may sometimes cause very serious reactions. 
Neki lijekovi mogu povećati nuspojave lijeka Suboxone te mogu ponekad uzrokovati vrlo ozbiljne reakcije.
Do not take Suboxone together with alcohol. 
Ne uzimajte Suboxone zajedno s alkoholom.
Patients with rare hereditary problems of galactose intolerance, should not take this medicine. 
Bolesnici s nasljednim problemima netolerancije galaktoze ne bi trebali uzimati ovaj lijek
However, Suboxone can be a target for people who abuse prescription medicine. 
Međutim, Suboxone može biti meta osobama koje zloupotrebljavaju lijekove koji se izdaju na recept.
• Misuse and abuse 
• Pogrešna uporaba i zlouporaba
Dublin 2 
Dublin 2 Irska
Naloxone has a mean half-life from plasma of 1.2 hours. 
Nalokson ima srednji poluvijek u plazmi od 1,2 sata.
Therefore, breastfeeding should be discontinued during treatment with Suboxone. 
Stoga dojenje treba prekinuti za vrijeme liječenja lijekom Suboxone.
o benzodiazepines: This combination may result in death due to respiratory depression of central origin. 
o benzodiazepinima: Ova kombinacija može dovesti do smrti zbog središnje prouzročene depresije disanja.
• a urinary disorder (especially linked to enlarged prostrate in men) 
• poremećaj mokrenja (koji je osobito povezan s uvećanom prostatom u muškaraca)
Symptomatic treatment of respiratory depression, and standard intensive care measures, should be implemented. 
Treba provesti simptomatsko liječenje respiratorne depresije i standardne mjere intenzivne njege.
Like all medicines, Suboxone can cause side effects, although not everybody gets them. 
Kao i svi lijekovi, Suboxone može uzrokovati nuspojave iako se neće javiti kod svakoga.
The dose on Monday and Wednesday should be twice the individually titrated daily dose, and the dose on Friday should be three times the individually titrated daily dose, with no dose on the intervening days. 
Doza koja se daje ponedjeljkom i srijedom treba biti dvostruko viša od individualno titrirane dnevne doze, a doza petkom treba biti tri puta viša od individualno titrirane dnevne doze, bez uzimanja doze u međuvremenu.
What Suboxone looks like and contents of the pack 
Kako Suboxone izgleda i sadržaj pakiranja
Patients should be monitored following medical withdrawal because of the potential for relapse. 
Bolesnike treba nadzirati nakon ustezanja lijeka od strane liječnika zbog mogućnosti pojave relapsa.
Do not take any other medicines whilst taking Suboxone without first talking to your doctor, especially: 
Nemojte uzimati bilo koje druge lijekove dok uzimate Suboxone bez prethodnog razgovora sa svojim liječnikom, osobito:
(see section 4.3 and 5.2). 
(vidjeti dijelove 4.4. i 5.2).
Buprenorphine/naloxone should be used during pregnancy only if the potential benefit outweighs the potential risk to the foetus. 
Buprenorfin/nalokson bi za vrijeme trudnoće trebalo koristiti isključivo ako potencijalna korist nadmašuje potencijalnu opasnost po fetus.
The maximum daily dose is 24 mg. 
Maksimalna dnevna doza je 24 mg.
Clear signs of withdrawal should be evident before taking your first dose of Suboxone. 
Jasni znakovi ustezanja trebali bi biti očiti prije uzimanja prve doze lijeka Suboxone.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. 
Pažljivo pročitajte cijelu uputu prije nego počnete uzimati ovaj lijek, jer sadrži Vama važne informacije.
Both Cmax and AUC of buprenorphine increased with the increase in dose (in the range of 4-16 mg), although the increase was less than dose-proportional. 
I Cmax i AUC buprenorfina povećali su se s povišenjem doze (u rasponu od 4-16 mg), iako povećanje nije bilo proporcionalno dozi, nego manje.
Depending on your condition, the dose of Suboxone may continue to be reduced under careful medical supervision, until eventually it may be stopped. 
Ovisno o Vašem stanju, sa snižavanjem doze lijeka Suboxone se može nastaviti pod pažljivim liječničkim nadzorom, sve do trenutka kad se eventualno može prekinuti.
Talk to your doctor before taking Suboxone if you have: 
Obratite se svom liječniku prije nego uzmete Suboxone ako imate:
Speech disorder Tremor 
Poremećaj govora Tremor
For any information about this medicine, please contact the Marketing Authorisation Holder: 
Za sve informacije o ovom lijeku, molimo obratite se nositelju odobrenja za stavljanje u promet gotovog lijeka:
Patients should be warned that it is extremely dangerous to self-administer non-prescribed benzodiazepines while taking this product, and should also be cautioned to use benzodiazepines concurrently with this product only as directed by their physician (see section 4.4). 
Bolesnike se mora upozoriti da je iznimno opasno samoprimjenjivati nepropisane benzodiazepine tijekom uzimanja ovog lijeka, a također ih treba upozoriti da uzimaju benzodiazepine zajedno s ovim lijekom isključivo prema uputama njihovog liječnika (vidjeti dio 4.4).
If you forget to take Suboxone Tell your doctor as soon as possible if you miss a dose. 
Ako ste zaboravili uzeti Suboxone Obavijestite svog liječnika čim prije ako ste propustili dozu.
Substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. 
Nadomjesno liječenje ovisnosti o opioidimau okviru medicinskog, socijalnog i psihološkog liječenja.
A number of cases of death due to respiratory depression have been reported, particularly when buprenorphine was used in combination with benzodiazepines (see section 4.5) or when buprenorphine was not used according to prescribing information. 
Prijavljeni su smrtni slučajevi zbog depresije disanja, osobito kad se buprenorfin rabio u kombinaciji s benzodiazepinima (vidjeti dio 4.5), ili kad se buprenorfin nije rabio u skladu s propisanim uputama.
Following intravenous administration, naloxone is rapidly distributed (distribution halflife ~ 4 minutes). 
Nakon intravenske primjene, nalokson se brzo distribuira (poluvrijeme distribucije ~ 4 minute).
Tell your doctor if you have any liver problems before you start treatment with Suboxone. 
Obavijestite svog liječnika ako imate bilo kakvih problema s jetrom prije nego počnete liječenje lijekom Suboxone.
If the dates for submission of a PSUR and the update of a RMP coincide, they can be submitted at the same time. 
U slučaju istovremenog PSUR-a i dopune RMP-a, možete ih podnijeti istovremeno.
Initial naloxone doses may range up to 2 mg and be repeated every 2-3 minutes until a satisfactory response is achieved, but should not exceed a 10 mg starting dose. 
Početne doze naloksona mogu iznositi do 2 mg i mogu se ponavljati svakih 2-3 minute do postizanja zadovoljavajuće reakcije, s tim da početna doza ne bi smjela biti viša od 10 mg.
Urine Abnormality 
Abnormalnosti urina
• seeing or hearing things that are not there (hallucinations). 
• vidnih ili slušnih priviđanja (halucinacija).
Peak plasma concentrations are achieved 90 minutes after sublingual administration. 
Vršne koncentracije u plazmi postižu se 90 minuta nakon sublingvalne primjene.
A doctor's assessment of your readiness for treatment will guide the timing of your first Suboxone dose. 
Liječnička procjena Vaše spremnosti za liječenje odredit će vrijeme kada ćete uzeti prvu dozu lijeka Suboxone.
After a time of successful treatment, you may agree with your doctor to reduce the dose gradually to a lower maintenance dose. 
Nakon uspješnog liječenja, možete se složiti s Vašim liječnikom da se doza postupno snizi na nižu dozu održavanja.
The effectiveness of buprenorphine, 8 mg per day was similar to that of the moderate active control dose, but equivalence was not demonstrated. 
Učinkovitost buprenorfina u dozi od 8 mg/dan bila je slična onoj aktivne kontrole s umjerenom dozom, iako ekvivalencija nije dokazana.
Deaths have also been reported in association with concomitant administration of buprenorphine and other depressants such as alcohol or other opioids. 
Smrtni slučajevi također su prijavljeni vezano uz istovremenu primjenu buprenorfina i drugih depresora poput alkohola i drugih opioida.
If you stop taking Suboxone 
Ako prestanete uzimati Suboxone
• severe tiredness, itching with yellowing of skin or eyes. 
• jakog umora, svrbeža sa žutom bojom kože ili očiju.
Indivior Europe Limited Telephone 0808 234 9243 
Telefon: 0800 222 899
Animal studies have shown a reduction in female fertility at high doses (systemic exposure > 2.4 times the human exposure at the maximum recommended dose of 24 mg buprenorphine, based on AUC). 
Ispitivanja na životinjama pokazala su smanjenje plodnosti ženki pri izloženosti visokim dozama (sistemska izloženost > 2,4 puta od izloženosti ljudi pri maksimalnoj preporučenoj dozi od 24 mg buprenorfina, na temelju AUC).
When taken during pregnancy, particularly late pregnancy, medicines like Suboxone may cause drug withdrawal symptoms including problems with breathing in your newborn baby. 
Ako se uzimaju tijekom trudnoće, osobito u kasnom stadiju trudnoće, lijekovi poput lijeka Suboxone mogu uzrokovati sindrom ustezanja uključujući probleme s disanjem u Vašeg novorođenčeta.
Dosage adjustment and maintenance therapy: 
Prilagodba doze i terapija održavanja:
• Dependence This product can cause dependence. 
Ovaj lijek može uzrokovati ovisnost.
• Starting treatment of Suboxone whilst dependent on heroin 
• Početak liječenja lijekom Suboxone dok ste ovisni o heroinu
Opioids should be administered with caution to elderly or debilitated patients. 
Opioide je potrebno koristiti uz oprez u starijih i oslabljenih bolesnika.
Tell your doctor immediately or seek urgent medical attention if you experience side effects, such as: 
Odmah obavijestite svojeg liječnika ili potražite hitnu medicinsku pomoć ako primijetite nuspojave, kao što su:
Liver damage has been reported after taking Suboxone, especially when the medicine is misused. 
Zabilježeni su slučajevi oštećenja jetre nakon uzimanja lijeka Suboxone, osobito prilikom pogrešne uporabe lijeka.
Packed in packs of 7 and 28 tablets. 
Pakirane su po 7 i 28 tableta.
Towards the end of pregnancy buprenorphine may induce respiratory depression in the newborn infant even after a short period of administration. 
Pred kraj trudnoće, buprenorfin može izazvati respiratornu depresiju u novorođenčeta, čak i nakon kratkog perioda primjene.
This product can cause withdrawal symptoms if you take it less than six hours after you use a short-acting opioid (e.g. morphine, heroin) or less than 24 hours after you use a long-acting opioid such as methadone. 
Ovaj lijek može uzrokovati simptome ustezanja ako ga uzmete manje od šest sati otkad ste zadnji put uzeli kratkodjelujući opioid (npr. morfij, heroin) ili manje od 24 sata nakon što ste uzeli dugodjelujući opioid poput metadona.
For patients who may require a lower buprenorphine dose, buprenorphine 0.4 mg may be used. 
U bolesnika kojima treba niža doza buprenorfina, može se koristiti buprenorfin od 0,4 mg.
The risks of using Suboxone in pregnant women are not known. 
Rizici uzimanja lijeka Suboxone u trudnica nisu poznati.
However, the dose given on any one day should not exceed 24 mg buprenorphine. 
Međutim, sveukupna dnevna doza nikada ne smije biti viša od 24 mg buprenorfina.
These include medicines used to treat epilepsy (such as carbamazepine and phenytoin), and medicines used to treat tuberculosis (rifampicin). 
To su lijekovi koji se koriste za liječenje epilepsije (poput karbamazepina i fenitoina) i lijekovi koji se koriste za liječenje tuberkuloze (rifampicin).
Suboxone may cause drowsiness. 
Suboxone može izazvati omamljenost.